You just read:

Boston Biomedical to Highlight Data for Cancer Stemness Inhibitor Napabucasin in Patients with Colorectal Cancer at 2017 ASCO GI

News provided by

Boston Biomedical Pharma, Inc.

18 Jan, 2017, 12:47 ET